Literature DB >> 27098530

Tailored circulatory intervention in adults with pulmonary hypertension due to congenital heart disease.

L E Couperus1, I R Henkens2, M R M Jongbloed2,3, M G Hazekamp4, M J Schalij2, H W Vliegen2.   

Abstract

BACKGROUND: Adults with pulmonary hypertension associated with congenital heart disease (PH-CHD) often have residual shunts. Invasive interventions aim to optimise pulmonary flow and prevent right ventricular failure. However, eligibility for procedures strongly depends on the adaptation potential of the pulmonary vasculature and right ventricle to resultant circulatory changes. Current guidelines are not sufficiently applicable to individual patients, who exhibit great diversity and complexity in cardiac anomalies. METHODS AND
RESULTS: We present four complex adult PH-CHD patients with impaired pulmonary flow, including detailed graphics of the cardiopulmonary circulation. All these patients had an ambiguous indication for shunt intervention. Our local multidisciplinary Grown-Ups with Congenital Heart Disease team reached consensus regarding a patient-tailored invasive treatment strategy, adjacent to relevant guidelines. Interventions improved pulmonary haemodynamics and short-term clinical functioning in all cases.
CONCLUSIONS: Individual evaluation of disease characteristics is mandatory for tailored interventional treatment in PH-CHD patients, adjacent to relevant guidelines. Both strict registration of cases and multidisciplinary and multicentre collaboration are essential in the quest for optimal therapy in this patient population.

Entities:  

Keywords:  Congenital heart defects; Intervention; Pulmonary hypertension; Right ventricular dysfunction

Year:  2016        PMID: 27098530      PMCID: PMC4887303          DOI: 10.1007/s12471-016-0833-7

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  27 in total

1.  Reduction in recalcitrant pulmonary hypertension after operation for atrial septal defect.

Authors:  H Yamauchi; S Yamaki; M Fujii; H Iwaki; S Tanaka
Journal:  Ann Thorac Surg       Date:  2001-09       Impact factor: 4.330

2.  Bosentan treatment in an adult with pulmonary hypertension due to patent ductus arteriosus permits surgical repair.

Authors:  Fotios A Mitropoulos; Sotiria C Apostolopoulou; Meletios A Kanakis; Spyridon Rammos; Constantine E Anagnostopoulos
Journal:  J Heart Lung Transplant       Date:  2007-11-19       Impact factor: 10.247

3.  Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: shunt lesions.

Authors:  Candice K Silversides; Annie Dore; Nancy Poirier; Dylan Taylor; Louise Harris; Matthias Greutmann; Lee Benson; Helmut Baumgartner; David Celermajer; Judith Therrien
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

4.  Measurement, interpretation and use of haemodynamic parameters in pulmonary hypertension associated with congenital cardiac disease.

Authors:  Antonio Augusto Lopes; Patrick W O'Leary
Journal:  Cardiol Young       Date:  2009-08-27       Impact factor: 1.093

5.  Adult patients with congenital heart disease and pulmonary arterial hypertension: first open prospective multicenter study of bosentan therapy.

Authors:  Ingram Schulze-Neick; Nadine Gilbert; Ralf Ewert; Christian Witt; Ekkehard Gruenig; Beate Enke; Mathias M Borst; Peter E Lange; Marius M Hoeper
Journal:  Am Heart J       Date:  2005-10       Impact factor: 4.749

6.  Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension.

Authors:  J Sandoval; J Gaspar; H Peña; L E Santos; J Córdova; K del Valle; A Rodríguez; T Pulido
Journal:  Eur Respir J       Date:  2011-02-24       Impact factor: 16.671

7.  Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance.

Authors:  Alicia M Maceira; Sanjay K Prasad; Mohammed Khan; Dudley J Pennell
Journal:  Eur Heart J       Date:  2006-11-06       Impact factor: 29.983

Review 8.  Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease.

Authors:  M A Gatzoulis; R Alonso-Gonzalez; M Beghetti
Journal:  Eur Respir Rev       Date:  2009-09

9.  Epidemiology of adult congenital heart disease: demographic variations worldwide.

Authors:  B J M Mulder
Journal:  Neth Heart J       Date:  2012-12       Impact factor: 2.380

10.  Advanced therapy for pulmonary arterial hypertension due to congenital heart disease: a clinical perspective in a new therapeutic era.

Authors:  M J Schuuring; S M Boekholdt; A Windhausen; B J Bouma; M Groenink; M Keijzers; R J De Winter; D R Koolbergen; N A Blom; B J M Mulder
Journal:  Neth Heart J       Date:  2011-12       Impact factor: 2.380

View more
  2 in total

1.  Pulmonary hypertension in the changing landscape of congenital heart disease: Global differences and a possible driver of end-stage heart failure.

Authors:  A Van De Bruaene; W Budts
Journal:  Neth Heart J       Date:  2016-06       Impact factor: 2.380

2.  Pulmonary hypertension: the importance of a multidisciplinary approach.

Authors:  M C Post; E E van der Wall
Journal:  Neth Heart J       Date:  2016-06       Impact factor: 2.380

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.